AstraZeneca: Sister of blood clot victim urges UK to get jabbed
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.
Blood clots associated with Covid vaccination have concerned some international officials, who have attached limitations to the AstraZeneca candidate. An isolated number of cases have followed European vaccine programmes, leading authorities to throw caution to the wind. Although they continue to research the connection, it remains poorly understood.
Are the AstraZeneca blood clots a coincidence?
Health authorities have identified a total of 79 blood clotting cases associated with the AstraZeneca vaccine out of the 20.2 million doses issued.
Of those, 19 people have died, including 13 women and six men.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) branded clotting “extremely rare and unlikely to occur” in those receiving the jab.
Approximately four in one million people will experience thrombo-embolic events.
Cerebral Venous Sinus Thrombosis (CVST) is the most common among jab recipients and has a fractionally lower incidence elsewhere.
Annual cases of CVST sit at around three to four per million, meaning the rates barely differ from those attributed to the jab by the MHRA.
The barely noticeable difference has led experts to call for additional information.
Among those is Harley Street Doctor Charlie Easmon, director of Your Excellent Health Service.
Dr Easmon told Express.co.uk, he would like to see more information on incidence rates to help shed light on cause and effect.
He said: “Since the background level of these events in the AZ vaccinated is very similar to those unvaccinated, to my knowledge, the Pfizer data shows statistically similar data.
“In my opinion, the incidence rates of thromboembolic events should be published with a ‘confidence interval’ range which would help to assess if they are coincidence or association.”
DON’T MISS
Pound set to plummet to biggest loss in seven months – ANALYSIS
EU vaccine supremo taunts Britain in coronavirus jibe – VIDEO
What does it feel like when you have a blood clot? – EXPLAINER
The European Medicines Agency (EMA) has previously stated the number of thromboembolic events associated with the jab is “no higher than the number seen in the general population”.
The MHRA has added clots remain “extremely rare” among those who have had the jab.
Regardless, they have advised healthcare personnel to administer the AstraZeneca vaccine only when “benefits from the protection from COVID-19 infection outweighs potential risks”.
Those receiving the jab should also stay aware of the symptoms of CVST, a potentially fatal condition.
Symptoms of CVST can include:
- Headache
- Blurred vision
- Fainting or loss of consciousness
- Loss of control over movement in part of the body
- Seizures
- Coma
Source: Read Full Article